HIV evolution in early infection: Selection pressures, patterns of insertion and deletion, and the impact of APOBEC

PLoS Pathogens

Volumn 5, Issue 5, 2009, Pages

  Wood, Natasha ^a,b   Bhattacharya, Tanmoy ^c,d   Keele, Brandon F ^e   Giorgi, Elena ^c,f   Liu, Michael ^g   Gaschen, Brian ^c   Daniels, Marcus ^c   Ferrari, Guido ^h   Haynes, Barton F ^h   McMichael, Andrew ^g   Shaw, George M ^e   Hahn, Beatrice H ^e   Korber, Bette ^c,d   Seoighe, Cathal ^a,b,i  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b CENTRE FOR HIGH PERFORMANCE COMPUTING   (South Africa)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d SANTA FE INSTITUTE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h DUKE UNIVERSITY   (United States)

ⁱ NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE; ENVELOPE GLYCOPROTEIN; EPITOPE; GLYCOPROTEIN GP 41; NUCLEOTIDE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; CYTIDINE DEAMINASE; VIRUS ENVELOPE PROTEIN;

ARTICLE; CODON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; GENE INSERTION; HLA SYSTEM; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFORMATION; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; MUTATION; PREDICTION; PROTEIN MOTIF; VIRUS TRANSMISSION; BIOLOGICAL MODEL; CROSS-SECTIONAL STUDY; GENETICS; INDEL MUTATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYSIOLOGY; VIROLOGY; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BASE SEQUENCE; CROSS-SECTIONAL STUDIES; CYTIDINE DEAMINASE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; INDEL MUTATION; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67249140561     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000414     Document Type: Article

References (65)

1. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, et al. (2008) Transmission of HIV-1CTL escape variants provides HLA-mismatched recipients with a survival advantage. Plos Pathogens 4(3): e1000033. doi:10.1371/journal.ppat. 1000033.
2. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, et al. (2004) Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Medicine 10: 275-281. (Pubitemid 38667618)
3. Wyatt R, Sodroski J (1998) The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 280: 1884-1888. (Pubitemid 28299385)
4. Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J (2007) HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry. Aids 21: 693-702. (Pubitemid 46568626)
5. Hollier MJ, Dimmock NJ (2005) The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: An analysis of sequence, structure, and function. Virology 337: 284-296. (Pubitemid 40798996)
6. Sattentau QJ (1998) HIV gp120: double lock strategy foils host defences. Structure 6: 945-949. (Pubitemid 28397916)
7. Root MJ, Hamer DH (2003) Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein. Proceedings of the National Academy of Sciences of the United States of America 100: 5016-5021. (Pubitemid 36542651)
8. Johnston MI, Fauci AS (2007) Current concepts: An HIV vaccine - Evolving concepts. New England Journal of Medicine 356: 2073-2081.
9. Burton DR, Stanfield RL, Wilson IA (2005) Antibody vs. HIV in a clash of evolutionary titans. Proceedings of the National Academy of Sciences of the United States of America 102: 14943-14948.
10. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, et al. (2004) Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14: 1229-1246.
11. Blay WM, Gnanakaran S, Foley B, Doria-Rose NA, Korber BT, et al. (2006) Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. Journal of Virology 80: 999-1014. (Pubitemid 43062911)
12. Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, et al. (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393: 705-711. (Pubitemid 28289663)
13. Zhang WT, Canziani G, Plugariu C, Wyatt R, Sodroski J, et al. (1999) Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 38: 9405-9416. (Pubitemid 29347265)
14. Rits-Volloch S, Frey G, Harrison SC, Chen B (2006) Restraining the conformation of HIV-1 Gp120 by removing a flexible loop. Embo Journal 25: 5026-5035. (Pubitemid 44607046)
15. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci. (Pubitemid 351830056)
16. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, et al. (2008) Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. Journal of Virology 82: 3952-3970.
17. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 17: 1871-1879. (Pubitemid 37070272)
18. Kosakovsky Pond SL, Frost SDW, Muse SV (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679. (Pubitemid 40424796)
19. Chohan B, Lang D, Sagar M, Korber B, Lavreys L, et al. (2005) Selection for human immunodeficiency virus type I envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. Journal of Virology 79: 6528-6531. (Pubitemid 40617257)
20. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, et al. (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303: 2019-2022. (Pubitemid 38393277)
21. Frost SDW, Liu Y, Pond SLK, Chappey C, Wrin T, et al. (2005) Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. Journal of Virology 79: 6523-6527. (Pubitemid 40617256)
22. Gray ES, Moore PL, Choge IA, Decker JM, Bibollet-Ruche F, et al. (2007) Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. Journal of Virology 81: 6187-6196. (Pubitemid 46878025)
23. Pathak VK, Temin HM (1990) Broad-Spectrum of Invivo Forward Mutations, Hypermutations, and Mutational Hotspots in A Retroviral Shuttle Vector After A Single Replication Cycle - Deletions and Deletions with Insertions. Proceedings of the National Academy of Sciences of the United States of America 87: 6024-6028.
24. Jones NA, Wei X, Flower DR, Wong M, Michor F, et al. (2004) Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. The Journal of Experimental Medicine 200: 1243-1265. (Pubitemid 39552566)
25. Frahm N, Baker B, Brander C (2008) Identification and Optimal Definition of HIV-Derived Cytotoxic T Lymphocyte (CTL) Epitopes for the Study of CTL Escape, Functional Avidity and Viral Evolution. pp 3-24.
26. Sagar M, Wu XL, Lee S, Overbaugh J (2006) Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. Journal of Virology 80: 9586-9598. (Pubitemid 44435633)
27. Suzuki Y, Nei M (2002) Simulation study of the reliability and robustness of the statistical methods for detecting positive selection at single amino acid sites. Molecular Biology and Evolution 19: 1865-1869. (Pubitemid 35388109)
28. Anisimova M, Nielsen R, Yang ZH (2003) Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 164: 1229-1236. (Pubitemid 36935693)
29. Shriner D, Nickle DC, Jensen MA, Mullins JI (2003) Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genetical Research 81: 115-121. (Pubitemid 36575835)
30. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SDW (2006) Automated phylogenetic detection of recombination using a genetic algorithm. Molecular Biology and Evolution 23: 1891-1901. (Pubitemid 44412875)
31. Edwards CTT, Holmes EC, Wilson DJ, Viscidi RP, Abrams EJ, et al. (2006) Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. Bmc Evolutionary Biology 6.
32. Frost LS, Leplae R, Summers AO, Toussaint A (2005) Mobile genetic elements: The agents of open source evolution. Nature Reviews Microbiology 3: 722-732. (Pubitemid 41195088)
33. Asquith B, Mclean AR (2007) In vivo CD8(+) T cell control of immunodeficiency virus infection in humans and macaques. Proceedings of the National Academy of Sciences of the United States of America 104: 6365-6370.
34. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine 10: 282-289. (Pubitemid 38667619)
35. Goulder P, Price D, Nowak M, RowlandJones S, Phillips R, et al. (1997) Coevolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunological Reviews 159: 17-29. (Pubitemid 27499857)
36. McMichael AJ, Rowland-Jones SL (2001) Cellular immune responses to HIV. Nature 410: 980-987. (Pubitemid 32335849)
37. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes. Science 283: 857-860. (Pubitemid 129501128)
38. Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, et al. (2006) HIV-1 epitope-specific CD8(+) T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. Journal of Immunology 176: 6130-6146.
39. Fernandez CS, Stratov I, De Rose R, Walsh K, Dale CJ, et al. (2005) Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. Journal of Virology 79: 5721-5731. (Pubitemid 40548241)
40. Loh L, Batten CJ, Petravic J, Davenport MP, Kent SJ (2007) In vivo fitness costs of different gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. Journal of Virology 81: 5418-5422.
41. Loh L, Petravic J, Batten CJ, Davenport MP, Kent SJ (2008) Vaccination and timing influence SIV immune escape viral dynamics in vivo. Plos Pathogens 4: e12. doi:10.1371/journal.ppat.0040012.
42. Allen TM, O'Connor DH, Jing PC, Dzuris JL, Mothe BR, et al. (2000) Tatspecific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390. (Pubitemid 30736016)
43. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, et al. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3: 212-217. (Pubitemid 27064707)
44. Li B, Gladden AD, Altfeld M, Kaldor JM, Cooper DA, et al. (2007) Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. Journal of Virology 81: 193-201. (Pubitemid 44975160)
45. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, et al. (2005) Selective escape from CD8(+) T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. Journal of Virology 79: 13239-13249. (Pubitemid 41508139)
46. Herbeck JT, Nickle DC, Learn GH, Gottlieb GS, Curlin ME, et al. (2006) Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. Journal of Virology 80: 1637-1644. (Pubitemid 43228705)
47. Peyerl FW, Bazick HS, Newberg MH, Barouch DH, Sodroski J, et al. (2004) Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. Journal of Virology 78: 13901-13910. (Pubitemid 39612787)
48. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, et al. (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic Tlymphocyte escape mutation in human immunodeficiency virus type 1 infection. Journal of Virology 78: 7069-7078. (Pubitemid 38781545)
49. Maydt J, Lengauer T (2006) Recco: recombination analysis using cost optimization. Bioinformatics 22: 1064-1071.
50. Kosakovsky Pond SL, Poon AFY, Zarate S, Smith DM, Little SJ, et al. (2008) Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Statistics in Medicine 27: 4779-4789.
51. Nielsen R, Yang ZH (1998) Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148: 929-936. (Pubitemid 28169008)
52. Yang W, Bielawski JP, Yang ZH (2003) Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. Journal of Molecular Evolution 57: 212-221. (Pubitemid 37026543)
53. Delport W, Scheffler K, Seoighe C (2009) Models of coding sequence evolution. Briefings in Bioinformatics 10: 97-109.
54. Yang ZH, Nielsen R (2000) Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Molecular Biology and Evolution 17: 32-43. (Pubitemid 30056990)
55. Wong WSW, Yang ZH, Goldman N, Nielsen R (2004) Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics 168: 1041-1051. (Pubitemid 39491478)
56. Yang ZH, Wong WSW, Nielsen R (2005) Bayes empirical Bayes inference of amino acid sites under positive selection. Molecular Biology and Evolution 22: 1107-1118. (Pubitemid 40471423)
57. Goldman N, Yang ZH (1994) Codon-Based Model of Nucleotide Substitution for Protein-Coding Dna-Sequences. Molecular Biology and Evolution 11: 725-736. (Pubitemid 24274881)
58. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic Biology 52: 696-704. (Pubitemid 37365050)
59. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, et al. (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315: 1583-1586. (Pubitemid 46449476)
60. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, et al. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288: 1789-1796. (Pubitemid 30399011)
61. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440-9445. (Pubitemid 37033947)
62. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo. Journal of Virology 77: 5037-5038. (Pubitemid 36402857)
63. Mansky LM, Temin HM (1995) Lower In-Vivo Mutation-Rate of Human- Immunodeficiency-Virus Type-1 Than That Predicted from the Fidelity of Purified Reverse-Transcriptase. Journal of Virology 69: 5087-5094.
64. Goonetilleke N, Moore S, Dally L, Winstone N, Cebere I, et al. (2006) Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8(+) T-cell epitopes. Journal of Virology 80: 4717-4728.
65. Bunce M (2002) PCR-Sequence-Specific Primer Typing of HLA Class I and Class II Alleles. pp 143-171.